-transparent.png){kind=logo}
A 66-year-old woman with malignant histiocytosis was treated with a combination of recombinant gamma interferon (GI-3) and etoposide. Following partial response to intravenous gamma interferon (9 x 10(6) units (U)/day) alone, the patient received an eight-months course of subcutaneous gamma interferon (0.5 x 10(6) U/day) and intravenous etoposide (100 mg/week). After two years, the patient remains in complete remission. The present case report discusses the successful use of combination gamma interferon and etoposide for the treatment of malignant histiocytosis.
Related Publications
H Takemori, and
Y Sakata, and
H Suzuki, and
T Yamaya, and
N Furugori, and
S Morimoto, and
Y Yoshida
December 2022,
Oncology letters,
H Takemori, and
Y Sakata, and
H Suzuki, and
T Yamaya, and
N Furugori, and
S Morimoto, and
Y Yoshida
January 1994,
Journal of Tongji Medical University = Tong ji yi ke da xue xue bao,
H Takemori, and
Y Sakata, and
H Suzuki, and
T Yamaya, and
N Furugori, and
S Morimoto, and
Y Yoshida
June 1994,
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
H Takemori, and
Y Sakata, and
H Suzuki, and
T Yamaya, and
N Furugori, and
S Morimoto, and
Y Yoshida
May 1988,
Gan to kagaku ryoho. Cancer & chemotherapy,
H Takemori, and
Y Sakata, and
H Suzuki, and
T Yamaya, and
N Furugori, and
S Morimoto, and
Y Yoshida
October 2015,
The Journal of dermatology,
H Takemori, and
Y Sakata, and
H Suzuki, and
T Yamaya, and
N Furugori, and
S Morimoto, and
Y Yoshida
December 2016,
Annals of surgical treatment and research,
H Takemori, and
Y Sakata, and
H Suzuki, and
T Yamaya, and
N Furugori, and
S Morimoto, and
Y Yoshida
September 1989,
Gan to kagaku ryoho. Cancer & chemotherapy,
H Takemori, and
Y Sakata, and
H Suzuki, and
T Yamaya, and
N Furugori, and
S Morimoto, and
Y Yoshida
May 1982,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
H Takemori, and
Y Sakata, and
H Suzuki, and
T Yamaya, and
N Furugori, and
S Morimoto, and
Y Yoshida
September 1996,
Gan to kagaku ryoho. Cancer & chemotherapy,
H Takemori, and
Y Sakata, and
H Suzuki, and
T Yamaya, and
N Furugori, and
S Morimoto, and
Y Yoshida
December 2023,
The Journal of dermatological treatment,
